City of Hope – Healthcare Data News

Tempus Welcomes City of Hope Comprehensive Cancer Center to Tempus+ Community

Tempus, a leader in artificial intelligence and precision medicine, today announced that City of Hope Comprehensive Cancer Center has joined Tempus+, a proprietary program that powers collaborative precision oncology research through...

June 14, 2022June 16, 2022 Collaborations Competitor News Data Partnership Oncology

Teclistamab Provides Substantial Clinical Benefit Over Real-World Physician’s Choice in Triple-Class Exposed R/R Myeloma

Teclistamab was found to have improved effectiveness in terms of progression-free survival (PFS), time to next treatment (TTNT), and overall survival (OS) vs real-world physician’s choice of therapy in patients...